Llwytho...
Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancer
With the advent of new drugs and therapeutic combinations for metastatic colorectal cancer, the prognosis for this often incurable disease is improving. In addition to traditional cytotoxic chemotherapeutics, targeted biologic therapies, such as cetuximab, panitumumab, bevacizumab, aflibercept and r...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Hepat Oncol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Future Medicine Ltd
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095158/ https://ncbi.nlm.nih.gov/pubmed/30190967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.14.13 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|